From new insight to new medicines

We look deeper into the biology of
growth factors and disease to discover
new treatments for patients

Scholar Rock® is discovering and developing a pipeline of innovative new medicines to treat a range of serious diseases with high unmet medical need.  Learn More

 
neuromuscular diseases

For Clinicians & Patients:
We are working to advance SRK-015, our lead drug program, into clinical trials for the improvement of muscle function in Spinal Muscle Atrophy, a rare genetic disease.  Learn More

 
  • Our Technology
    Supracellular Activation is a proprietary approach for highly selective targeting of growth factors.

    MORE >

CONTACT  |  SITEMAP  | 
 |  SITE DESIGN
“Scholar Rock” is a registered trademark of Scholar Rock, Inc.  |  © 2018 Scholar Rock All Rights Reserved.
Back to Top
 

The site you are about to visit is maintained by another organization, which is solely responsible for its content. As we cannot control the content or privacy practices of any third-party websites, we encourage you to read the privacy policy of every website you visit.

Continue   Cancel